Effect of matrix metalloproteinases on the longitudinal change in Alzheimer’s disease (AD) pathology and cognitive function in patients with mild cognitive impairment due to AD

MLA

Yuhei Chiba, et al. “Effect of Matrix Metalloproteinases on the Longitudinal Change in Alzheimer’s Disease (AD) Pathology and Cognitive Function in Patients with Mild Cognitive Impairment Due to AD.” Alzheimer’s & Dementia, vol. 16, Dec. 2020. EBSCOhost, https://doi.org/10.1002/alz.037123.

APA

Yuhei Chiba, Keiko Ide, Akira Suda, Akitoyo Hishimoto, Kie Abe, Asuka Yoshimi, & Saki Hattori. (2020). Effect of matrix metalloproteinases on the longitudinal change in Alzheimer’s disease (AD) pathology and cognitive function in patients with mild cognitive impairment due to AD. Alzheimer’s & Dementia, 16. https://doi.org/10.1002/alz.037123

Chicago

Yuhei Chiba, Keiko Ide, Akira Suda, Akitoyo Hishimoto, Kie Abe, Asuka Yoshimi, and Saki Hattori. 2020. “Effect of Matrix Metalloproteinases on the Longitudinal Change in Alzheimer’s Disease (AD) Pathology and Cognitive Function in Patients with Mild Cognitive Impairment Due to AD.” Alzheimer’s & Dementia 16 (December). doi:10.1002/alz.037123.